Skip to content
AwardedCzechiaGoodsCZK 74,659,000

Antidiabetika XIII. – Forxiga, Xigduo

Published
Published 11 August 2025
Deadline
Closed 9 September 2025

Overview

Předmětem veřejné zakázky jsou dodávky léčivých přípravků obsahující účinné látky dapagliflozin a kombinaci dapagliflozin/metformin (ATC A10BK01 a A10BD15) pro léčbu pacientů ve schválených indikacích dle SPC platného ke dni podání nabídek.

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 74,659,000
Procedure
Open
SME suitable
Yes
Published
11 August 2025
Deadline
Closed
Classification (CPV)
Medicinal products used in diabetes

Award outcome

Awarded value
CZK 74,658,730
Award date
12 September 2025
Contract period
11 October 2025 → 9 October 2029
Winner
  • PHOENIX lékárenský velkoobchod, s.r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    8 October 2025

  2. Contract Notice

    11 August 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Antidiabetika XIII. – Forxiga, Xigduo — won by PHOENIX lékárenský velkoobchod, s.r.o. — Skim